GMAB vs ONC: stock comparison and AI forecast
Genmab A/S (GMAB) and Beone Medicines Ltd. (ONC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GMAB Genmab A/S
- Market Cap
- $36.34B
- P/E Ratio
- 2.3x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
ONC Beone Medicines Ltd.
- Market Cap
- $41.07B
- P/E Ratio
- 1245.8x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ONC is 1.1 times larger than GMAB by market capitalization ($41.07B against $36.34B).
- GMAB trades at 2.3 times trailing earnings, ONC at 1245.8 times.
- GMAB carries 1.20 times debt per unit of equity, against 0.77 times for ONC.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GMAB | ONC |
|---|---|---|
| Market Cap | $36.34B | $41.07B |
| P/E Ratio | 2.27x | 1245.79x |
| P/B Ratio | – | 7.94x |
| EPS | $24.89 | $0.29 |
| Book Value/Share | – | $45.51 |
| Revenue/Share | $8.43 | $53.91 |
| FCF/Share | $2.84 | $11.70 |
Profitability & Margins
| Metric | GMAB | ONC |
|---|---|---|
| ROIC | 92.3% | 13.1% |
| Gross Margin | 95.4% | 88.9% |
| Operating Margin | 29.6% | 15.1% |
| EBT Margin | 41.0% | 14.2% |
| Tax Rate | 18.9% | 24.5% |
Financial Health
| Metric | GMAB | ONC |
|---|---|---|
| Current Ratio | 2.02x | 3.40x |
| Quick Ratio | 2.01x | 3.06x |
| D/E Ratio | 1.20x | 0.77x |
| Financial Leverage | 2.20x | 1.77x |
| Interest Coverage | – | 24.1x |
| Working Capital | $229M | $5.10B |
Cash Flow
| Metric | GMAB | ONC |
|---|---|---|
| Operating Cash Flow | $1.87B | $1.48B |
| Free Cash Flow | $1.83B | $1.33B |
| Capital Spending | -$46M | -$154M |
| OCF Growth YoY | -25.3% | 159.8% |
| FCF Growth YoY | 0.0% | 443.3% |
| FCF/Sales | 33.7% | 21.7% |
| CapEx/Sales | 0.8% | 2.5% |
Operational Efficiency
| Metric | GMAB | ONC |
|---|---|---|
| Asset Turnover | 2.77x | 0.67x |
| Receivables Turnover | 32.1x | 5.8x |
| Inventory Turnover | 91.9x | – |
| Fixed Assets Turnover | 233.4x | 3.7x |
| Days Sales Outstanding | 11 days | 63 days |
| Days Inventory | 4 days | – |
Income Statement
| Metric | GMAB | ONC |
|---|---|---|
| Total Revenue | $5.43B | $6.13B |
| Operating Income | $1.61B | $923M |
| R&D Expense | $2.51B | $2.29B |
| SG&A Expense | $947M | $2.23B |
| Cost of Goods Sold | $251M | – |
Dividend & Shareholder Information
| Metric | GMAB | ONC |
|---|---|---|
| Shares Outstanding | 643M | 114M |
| EPS Growth | -17.6% | – |
GMAB vs ONC: stock comparison and AI forecast
Which is bigger, GMAB or ONC?
ONC is 1.1 times larger than GMAB by market capitalization ($41.07B against $36.34B).
Which is cheaper on earnings, GMAB or ONC?
GMAB trades at 2.3 times trailing earnings, ONC at 1245.8 times.
Which one does Intratio's AI model rank higher, GMAB or ONC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.